National and Kapodistrian University of Athens
Ο καρκίνος του παχέος εντέρου: απομόνωση μεμβρανικών και κυτταροπλασματικών πρωτεϊνών, ιστών του παχέος εντέρου σε βιοχημικό επίπεδο
Abstract
dc:descriptionIn this study one hundred and seventy human tissues were collected out of eighty five patients. Eighty five were cancer tissues and the rest were mirror biopsy tissues. Ten out of the eighty five patients were diagnosed with Grade A colon adenocarcinoma according to Duke’s classification, thirty five were diagnosed with Grade B colon adenocarcinoma and the rest with Grade C colon adenocarcinoma. The tissues were fractionated in cytoplasmic and membrane fractions and were analysed with 2D- Electrophresis. Furthermore, twelve tissues were collected out of six patients. Six of these tissues were cancer tissues and six mirror biopsy tissues. Two out of the six patients were diagnosed with Grade A colon adencarcinoma, two with Grade B colon adenocarcinoma and two with Grade C colon adenocarcinoma. These tissues were analysed with immunohistochemistry against Calreticulin expression.After comparison of the 2D-Gels of the normal and malignant states differences in the expression levels of Albumin, Hemoglobin, al-antitrypsin and Actin were noted. Nevertheless these differences were assessed as insignificant. Additionally three qualitative and eight quantitative differences in protein expression came up. Two out of three proteins that consist the qualitative differences were located in the cytosolic fractions and the remaining one in the membrane fraction.The two aforementioned proteins were not identified and were named Π3 and Π4. Π3 (pl:5.53, MW:13805) shows up in most of the cancer sample gels and is totally absent from all the mirror biopsy ones. On the contrary Π4(ρΙ:4.53, MW:39458) shows up in most of the mirror biopsy sample gels while being absent from all the cancer sample ones. The last protein that was located at the membrane fraction was not identified either and was called Π6. Π6 (pl:6.51, MW:11000) shows up in almost all the cancer sample gels and is absent from the mirror biopsy ones.All eight proteins that consist the qualitative differences were all located in the cytosolic fraction. Five out of these eight proteins were identified by gel to gel comparison with reference gels available over the internet. These proteins are the following: Calreticulin (pl:4.40, MW:58700), ERP29 (pl:5.65, MW:26362), Ubiquitin99(pl:6.84, MW:8761), FABP (pl:5.82, MW:13370) and GSTP1 (pl:5.42, MW:22880). Calreticulin’s identification was verified with Immunoblotting.Calreticulin expression levels in the cancer sample 2D gels are increased when compared with the expression levels of the protein in the mirror biopsy samples. That applies for all three stages of the disease. The functionality of calreticulin is very interesting. The protein is responsible for collecting and storing Ca+2, it controls the protein and glycoprotein folding in the cytoplasm and it participates in the control of transcription of specific proteins which participate in the cell adhesion process. This process is a very crucial for tumour spreading and métastasés. Bearing in mind that calreticulin expression levels increase while the disease progresses, plus the fact that the protein in mainly overexpressed in the low differentiation regions of the tissues (as shown in the immunohistochemistry section of this study) we can suggest that Calreticulin’s functional role is directly associated to tumour aggressiveness spreading and métastasés.The expression levels of ERP29 increase in Stage A cancer samples and decrease in Stage B and C ones, relative to the expression levels of the protein in the corresponding mirror biopsy samples. ERP29 is located in the endoplasmic reticulum and is activated in stress conditions. Its functionality is associated to protein folding and secretion, processes very important for cellular communication. ERP29 is very interesting because it is a protein very recently identified and our knowledge of its complete functionality is far from complete. Furthermore it seems to have common functionalities to Calreticulin.The expression levels of Ubiquitin clearly increase in all the cancer samples of all the stages relative to the ones in the mirror biopsy samples. Ubiquitin participates in protein degradation and intracellular transport. Fellow researchers have demonstrated that Ubiquitin also controls several transcription factors as well as several protein-protein interactions. Bearing that in mind that ubiquitin levels increase in cancer could biochemically indicate increased protein degradation, hence increased metabolic rate of the cancer cells. Furthermore changes in the expression levels of ubiquitin could cause differentiation in the transcription of several proteins.The expression levels of FABP decrease in the Stage A and C cancer samples, while they increase in the stage B one relative to the protein expression levels in the100mirror biopsy samples. FABP regulates lipid transport and metabolism and is abundant in the cytoplasm. FABP expression at the transcription level is regulated by the PPARy transcription factor. This transcription factor’s activation under specific circumstance inhibits cellular growth and promotes cellular differentiation in a broad set of cancer cell lines coming from large intestine epithelium. Furthermore PPARy controls the transcription of proteins responsible for cellular growth, 3 different genes belonging to the family carcinoembryonic antigens and the transcription of proteins participating in the mechanism of extracellular adhesion. Fellow researchers have shown that FABP’s expression colon cancer adenocarcinomas was not uniform. They found that cancer cells in the adenocarcinoma that had exactly the same morphology did not uniformly express FABP. The same observation was made for metastatic sites coming from colon cancer adenocarcinomas. This is an indication that even though cancer cells have exactly the same morphology under the microscope are actually biochemically different. FABP could provide a marker for more competent classification of cancer cell populations in an adenocarcinoma.The expression levels of GSTP1 increase in all the cancer samples in comparison to the mirror biopsy samples. GSTP1 belongs to an enzyme class that plays important role in the removal of toxic agents which act probably as carcinogenic factors. In the current study an increase in the levels of this protein is observed in the cancer samples fact that contradicts the aforementioned functionality. Nevertheless fellow researchers have demonstrated that in MCF7 cells which presented high resistance to chemotherapiutical agents, the levels of GSTP1 were 18fold increased in comparison to other cells from the same cell line that lacked this resistance.The three proteins that consist the remaining quantitative differences were not identified and were named Π1 (pi: 4.95 MW: 31514), Π2 (pi: 6.12 MW: 11569) and Π5 (pi: 5.20 MW: 23274).The expression levels of Π1 increase in the cancer samples relative to the ones in the mirror biopsy samples.The expression levels of Π2 increase in the Stage A cancer samples and decrease in the Stages B and C cancer samples in comparison to the expression levels of the mirror biopsy samples.101The expression levels of Π5 decrease in the Stages A and C cancer samples and increase in the Stage B cancer samples in comparison to mirror biopsy samples.The three proteins consisting the qualitative differences and the three ones consisting the quantitative differences which remained undefined are going to be identified with mass spectrometry. Additionally further study on the functionality of these proteins will be performed utilising molecular biology techniques, in order for colon cancer specific markers to be produced.102
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2004
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Vougas, Konstantinos
- Βουγάς, Κωνσταντίνος
Subjects
dc:subject × 20- Καρκίνος
- Ηλεκτροφόρηση δύο διαστάσεων
- Παχύ έντερο
- Ανοσοϊστοχημεία
- Καλρετικουλίνη
- Ουβικιτίνη
- Καρκινικοί δείκτες
- Colon cancer
- 2D electrophoresis
- Immunohistochemistry ( IHC)
- Calreticulin
- Ubiquitin
- ERp29
- FABP
- GSTP1
- Tumor markers
- Ιατρική και Επιστήμες Υγείας
- Βασική Ιατρική
- Medical and Health Sciences
- Basic Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/25301